Scientists have developed a subretinal implant that allows people with age-related macular degeneration (AMD) to read again under normal lighting conditions.
Researchers have just announced that a new retinal implant has enabled individuals who were previously functionally blind due to advanced AMD to regain the ability to read. The device, measuring only 2 mm by 2 mm and about 30 µm thick, is surgically implanted beneath the retina.
The implant acts as a replacement for lost photoreceptor cells — it processes incoming light and transmits signals to the optic nerve, effectively recreating visual information.
Patients reported that, under normal lighting conditions, they were able to recognize letters and shapes that had previously appeared only as blurry, indistinguishable smudges.
However, this doesn’t mean that people with age-related macular degeneration will suddenly regain full vision or be able to read effortlessly.
Despite its groundbreaking potential, the technology still faces significant challenges: ensuring long-term safety and durability, improving visual resolution to approach normal levels, and reducing production costs so that the treatment becomes widely accessible.
In the long run, innovations like this could transform how retinal diseases are treated and represent a major milestone in retinal prosthetics — implantable devices designed to restore vision to blind individuals. But there’s still a long way to go.